Cara Therapeutics Inc (STU:69C)
€ 0.2286 -0.0092 (-3.87%) Market Cap: 12.94 Mil Enterprise Value: -32.64 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 26/100

Q4 2023 Cara Therapeutics Inc Earnings Call Transcript

Mar 04, 2024 / 09:30PM GMT
Release Date Price: €1.02 (+33.55%)
Operator

Thank you for standing by, and welcome to Cara Therapeutics fourth quarter and full year 2023 earnings conference call. (Operator Instructions) I would now like to hand the call over to Matt Murphy, Manager of Investor Relations. Please go ahead.

Matt Murphy
Cara Therapeutics Inc - Investor Relations and Business Development Manager

Thank you, operator, and good afternoon. After market closed today, Cara issued a news release announcing the company's financial and operating results for the fourth quarter and full year 2023. Copies of this news release can be found in the Investors section of our website at caratherapeutics.com.

Before we begin, let me remind you that during the course of this conference call, we will be making certain forward-looking statements about Cara and our program based on management's current plans and expectations. These statements are being made under the Private Securities Litigation Reform Act of 1995, and are subject to risks and uncertainties.

Actual results may differ materially due to various factors and Cara

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot